BK vs. PFE
Compare and contrast key facts about The Bank of New York Mellon Corporation (BK) and Pfizer Inc. (PFE).
Performance
BK vs. PFE - Performance Comparison
Loading graphics...
BK vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BK The Bank of New York Mellon Corporation | 2.64% | 54.45% | 51.90% | 18.52% | -19.14% | 40.55% | -12.91% | 9.56% | -10.85% | 15.68% |
PFE Pfizer Inc. | 14.66% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Fundamentals
BK:
$83.60B
PFE:
$159.66B
BK:
$7.82
PFE:
$1.36
BK:
15.18
PFE:
20.61
BK:
0.98
PFE:
0.37
BK:
2.15
PFE:
2.56
BK:
2.12
PFE:
1.72
BK:
$39.24B
PFE:
$62.58B
BK:
$19.86B
PFE:
$44.01B
BK:
$8.36B
PFE:
$15.10B
Returns By Period
In the year-to-date period, BK achieves a 2.64% return, which is significantly lower than PFE's 14.66% return. Over the past 10 years, BK has outperformed PFE with an annualized return of 15.29%, while PFE has yielded a comparatively lower 4.32% annualized return.
BK
- 1D
- 3.00%
- 1M
- -0.39%
- YTD
- 2.64%
- 6M
- 9.90%
- 1Y
- 44.42%
- 3Y*
- 41.57%
- 5Y*
- 23.54%
- 10Y*
- 15.29%
PFE
- 1D
- 1.12%
- 1M
- 1.56%
- YTD
- 14.66%
- 6M
- 14.02%
- 1Y
- 18.86%
- 3Y*
- -6.22%
- 5Y*
- -0.14%
- 10Y*
- 4.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BK vs. PFE — Risk / Return Rank
BK
PFE
BK vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Bank of New York Mellon Corporation (BK) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BK | PFE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.89 | 0.71 | +1.18 |
Sortino ratioReturn per unit of downside risk | 2.37 | 1.17 | +1.20 |
Omega ratioGain probability vs. loss probability | 1.35 | 1.15 | +0.21 |
Calmar ratioReturn relative to maximum drawdown | 3.59 | 1.32 | +2.27 |
Martin ratioReturn relative to average drawdown | 11.09 | 3.18 | +7.91 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BK | PFE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.89 | 0.71 | +1.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.96 | -0.01 | +0.97 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 0.18 | +0.38 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 0.26 | +0.08 |
Correlation
The correlation between BK and PFE is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
BK vs. PFE - Dividend Comparison
BK's dividend yield for the trailing twelve months is around 1.74%, less than PFE's 6.13% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BK The Bank of New York Mellon Corporation | 1.74% | 1.72% | 2.32% | 3.04% | 3.12% | 2.24% | 2.92% | 2.34% | 2.21% | 1.60% | 1.52% | 1.65% |
PFE Pfizer Inc. | 6.13% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Drawdowns
BK vs. PFE - Drawdown Comparison
The maximum BK drawdown since its inception was -72.28%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for BK and PFE.
Loading graphics...
Drawdown Indicators
| BK | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.28% | -58.96% | -13.32% |
Max Drawdown (1Y)Largest decline over 1 year | -12.95% | -12.59% | -0.36% |
Max Drawdown (5Y)Largest decline over 5 years | -40.45% | -58.96% | +18.51% |
Max Drawdown (10Y)Largest decline over 10 years | -50.49% | -58.96% | +8.47% |
Current DrawdownCurrent decline from peak | -7.04% | -42.75% | +35.71% |
Average DrawdownAverage peak-to-trough decline | -18.77% | -17.33% | -1.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.19% | 6.13% | -1.94% |
Volatility
BK vs. PFE - Volatility Comparison
The current volatility for The Bank of New York Mellon Corporation (BK) is 5.35%, while Pfizer Inc. (PFE) has a volatility of 6.75%. This indicates that BK experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BK | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.35% | 6.75% | -1.40% |
Volatility (6M)Calculated over the trailing 6-month period | 15.87% | 18.50% | -2.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.69% | 26.73% | -3.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.62% | 25.46% | -0.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.11% | 23.90% | +3.21% |
Financials
BK vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between The Bank of New York Mellon Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BK vs. PFE - Profitability Comparison
BK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, The Bank of New York Mellon Corporation reported a gross profit of 5.21B and revenue of 8.87B. Therefore, the gross margin over that period was 58.7%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a gross profit of 12.29B and revenue of 17.56B. Therefore, the gross margin over that period was 70.0%.
BK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, The Bank of New York Mellon Corporation reported an operating income of 1.85B and revenue of 8.87B, resulting in an operating margin of 20.8%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported an operating income of 3.69B and revenue of 17.56B, resulting in an operating margin of 21.0%.
BK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, The Bank of New York Mellon Corporation reported a net income of 1.46B and revenue of 8.87B, resulting in a net margin of 16.5%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a net income of -1.65B and revenue of 17.56B, resulting in a net margin of -9.4%.